Human Pulmonary Endothelial Cells Search Results


99
ATCC human pulmonary artery endothelial cells
Figure 4. EndT and EndMT of Metastatic Melanoma Cells in Mouse (A) Whole-mount staining of pulmonary artery with GFP+ cells located at the endothelium (Videos S1, S2, and S3). Bars: 10 mm. (B and C) EndT occurred in lymph nodes. EndT occurred in LYVE-1+ lymphatic vessles (B) and CD31+ blood vessels (C) in lymph nodes. Bars: 20 mm. (D) LYVE-1 immunostaining on lung cryosections. Bar: 20 mm. (E–J) Immunostaining indicated EndT is transient during tumor progression. At primary tumor sites, GFP+ cells were CD31-, VE-cadherin+ (E and H), while in the lung blood vessels, GFP+ cells were both CD31+ and VE-cadherin+ (F and I). GFP+ cells lost both <t>endothelial</t> markers when populating metastases in the lung (G and J). Bars: 20 mm. (K) CD31+/a-SMA+/GFP+ cell (arrowhead) inside the alveolar capillary. CD31+/aSMA+/GFP cell (arrow) near the GFP+ cell showed the same phenotype. It is possible that this is an authentic vascular endothelial cell undergoing EndMT or a metastatic cell that was not labeled with GFP. Bars: 10 mm. (A–K) Mice, n R 3. (L) Correlation between the number of GFP+ cells per vessel and the number of metastasis foci or the size of metastasis foci per mouse. The number of GFP+ cells/vessel vs. number of metastasis foci, r = 0.7950, p = 0.03*; number of GFP+ cells/vessel vs. metastasis size, r = 0.8012, *p = 0.03. Mice, n = 7.
Human Pulmonary Artery Endothelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Primary+Pulmonary+Artery+Endothelial+Cells%3B+Normal%2C+Human/pm32553158-222-0-6
Average 99 stars, based on 1 article reviews
human pulmonary artery endothelial cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
PromoCell human pulmonary microvascular endothelial cells hpmecs
FIGURE 2 | High physiological shear stress induces most prominently iRhom1 in <t>endothelial</t> cells from different vascular beds. HUVECs, HUAECs, HAMECs, and <t>HPMECs</t> were cultured for 24 h with a laminar shear stress of 30 dyn/cm2. Cells were then analyzed for mRNA expression of KLF2 (A), NOS3 (B), RHBDF1 (C), RHBDF2 (D), ADAM17 (E), and ADAM10 (F) in relation to a reference gene index consisting of GAPDH and TBP. The three independent experiments were performed with HUVECs and HUAECs from three different donors and HAMECs and HPMECs from two different donors. Data are shown as mean + standard deviation (SD) and as black and gray dots representing the individual data points. Statistical differences to the static control are indicated by asterisks (*p < 0.05, **p < 0.01, and ***p < 0.001). Significant differences between the different endothelial cell types were marked with different letters (a, b, c, and d). Each group with one letter is significantly different from a group with another letter.
Human Pulmonary Microvascular Endothelial Cells Hpmecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Human+Pulmonary+Microvascular+Endothelial+Cells/pm33335915-62-0-8
Average 96 stars, based on 1 article reviews
human pulmonary microvascular endothelial cells hpmecs - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

95
PromoCell pulmonary artery endothelial cells hpaecs
Validation of Selected Genes With the Use of RT 2 Profiler PCR Array and qPCR Analysis (A) Schematic representation of the experimental flow, including the cultivation of chronic thromboembolic pulmonary hypertension (CTEPH) <t>endothelial</t> cells (ECs) from pulmonary endarterectomy (PEA) specimens and preparation for further analysis. (B to I) Real-time qPCR analysis (using custom-designed RT 2 Profiler PCR assay or qPCR with custom oligonucleotides) of CTEPH-ECs (7 biological repeats) compared with human pulmonary arterial endothelial cells <t>(HPAECs)</t> (3 biological repeats) for genes (B) involved in extracellular matrix organization (ie, CD44 molecule [ CD44 ], collagen type 1 alpha 1 chain - ( COL1A1 ), collagen type 1 alpha 2 chain [ COL1A2 ], collagen type 3 alpha 1 chain [ COL3A1 ], collagen type 6 alpha 3 chain [ COL6A3 ], fibrillin 2 [ FBN2 ], matrix metalloproteinase 1 [ MMP1 ], and nidogen 1 [ NID1 ]) or belonging to the biological pathways (C) hemostasis (ie, ADAM metallopeptidase with thrombospondin type 1 motif 13 [ ADAMTS13 ], C-X-C motif chemokine ligand 8 [ CXCL8 or IL8 ], selectin E [ CD62E ], selectin P [ CD62P ], endothelial protein C receptor [ PROCR ], coagulation factor III [ F3 ], plasminogen activator inhibitor-1 [ PAI-1 ], serpin family G member 1 [ SERPING1 ], von Willebrand factor [ VWF ], transgelin [ TAGLN ], tissue factor pathway inhibitor [ TFPI ], tissue-type plasminogen activator [ TPA ], and thrombomodulin [ THBD ]), (D) signal transduction (ie, smooth muscle α-actin [ ACTA2 ], chemokine C-X-C motif ligand 6 [ CXCL6 ], Dickkopf-related protein 1 [ DKK1 ], Gata-binding protein 3 [ GATA3 ], neurogenic locus Notch homolog protein 3 [ NOTCH3 ], and thrombospondin [ THBS2 ]), (E) immune system (ie, C-C motif chemokine ligand 2 [ CCL2 ], cathepsin K [ CTSK ], cathepsin S [ CTSS ], intercellular adhesion molecule-1 [ ICAM1 ], interleukin-1β [ IL1B ], IL6 , tumor necrosis factor-α-induced protein 3 [ TNFAIP3 ], TNF receptor superfamily member 1B [ TNFRSF1B ], vascular cell adhesion molecule-1 [ VCAM1 ]), (F) metabolism (ie, lipase H [ LIPH ], lymphatic vessel endothelial hyaluronan receptor 1 [ LYVE1 ], prostaglandin 2 [ PTGIS ], prostaglandin endoperoxide synthase 1 [ PTGS1 ], and Shisa family member 3 [ SHISA3 ]), (G) metabolism of proteins (ie, ADAM metallopeptidase with thrombospondin type 1 motif 18 [ ADAMTS18 ], pappalysin 1 [ PAPPA ], syndecan 2 [ SDC2 ], stanniocalcin 2 [ STC2 ], and transforming growth factor-β-induced [ TGFBI ]), and (H) cell cycle control (ie, cyclin A1 [ CCNA1 ], cyclin D2 [ CCND2 ], and cyclin-dependent kinase 6 [ CDK6 ]), as well as (I) playing a role in TGFβ signaling (ie, bone morphogenetic protein and activin membrane bound inhibitor [ BAMBI ], follistatin like protein 3 [ FSTL3 ], periostin [POSTN ], transforming growth factor-β1 [ TGFB1 ], and TGFB2 ). Quantitative data are presented as mean ± SEM. P values were determined with the use of Student’s t -test for normally distributed values ( ACTA2 , ADAMTS13 , DKK1 , F3 , FBN2 , LIPH , NID1 , PAI-1 , PTGIS , PTGS1 , POSTN , SDC2 , THBS2 , TFPI , TNFRSF1B , and VWF ) and Mann-Whitney U -test for values that did not pass the normality test ( ADAMTS18 , BAMBI , BIGH3 , CCL2 , CCNA1 , CCND2 , CD44 , CD62E , CD62P , CDK6 , COL1A1 , COL1A2 , COL3A1 , COL6A3 , CTSK , CTSS , CXCL6 , CXCL8 , FSTL3 , GATA3 , ICAM1 , IL1B , IL6 , LYVE1 , MMP1 , NOTCH3 , PAPPA , PROCR , SERPING1 , SHISA3 , STC2 , TAGLN , TGFB1 , TGFB2 , THBD , TNFAIP3 , TPA , and VCAM1 ) and are shown within the graph: ∗ P < 0.05; ns = nonsignificant. Data points in blue are from male patients, green from female patients.
Pulmonary Artery Endothelial Cells Hpaecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Human+Pulmonary+Artery+Endothelial+Cells/pmc10864968-35-7-12
Average 95 stars, based on 1 article reviews
pulmonary artery endothelial cells hpaecs - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

94
ATCC pulmonary artery endothelial cells
Validation of Selected Genes With the Use of RT 2 Profiler PCR Array and qPCR Analysis (A) Schematic representation of the experimental flow, including the cultivation of chronic thromboembolic pulmonary hypertension (CTEPH) <t>endothelial</t> cells (ECs) from pulmonary endarterectomy (PEA) specimens and preparation for further analysis. (B to I) Real-time qPCR analysis (using custom-designed RT 2 Profiler PCR assay or qPCR with custom oligonucleotides) of CTEPH-ECs (7 biological repeats) compared with human pulmonary arterial endothelial cells <t>(HPAECs)</t> (3 biological repeats) for genes (B) involved in extracellular matrix organization (ie, CD44 molecule [ CD44 ], collagen type 1 alpha 1 chain - ( COL1A1 ), collagen type 1 alpha 2 chain [ COL1A2 ], collagen type 3 alpha 1 chain [ COL3A1 ], collagen type 6 alpha 3 chain [ COL6A3 ], fibrillin 2 [ FBN2 ], matrix metalloproteinase 1 [ MMP1 ], and nidogen 1 [ NID1 ]) or belonging to the biological pathways (C) hemostasis (ie, ADAM metallopeptidase with thrombospondin type 1 motif 13 [ ADAMTS13 ], C-X-C motif chemokine ligand 8 [ CXCL8 or IL8 ], selectin E [ CD62E ], selectin P [ CD62P ], endothelial protein C receptor [ PROCR ], coagulation factor III [ F3 ], plasminogen activator inhibitor-1 [ PAI-1 ], serpin family G member 1 [ SERPING1 ], von Willebrand factor [ VWF ], transgelin [ TAGLN ], tissue factor pathway inhibitor [ TFPI ], tissue-type plasminogen activator [ TPA ], and thrombomodulin [ THBD ]), (D) signal transduction (ie, smooth muscle α-actin [ ACTA2 ], chemokine C-X-C motif ligand 6 [ CXCL6 ], Dickkopf-related protein 1 [ DKK1 ], Gata-binding protein 3 [ GATA3 ], neurogenic locus Notch homolog protein 3 [ NOTCH3 ], and thrombospondin [ THBS2 ]), (E) immune system (ie, C-C motif chemokine ligand 2 [ CCL2 ], cathepsin K [ CTSK ], cathepsin S [ CTSS ], intercellular adhesion molecule-1 [ ICAM1 ], interleukin-1β [ IL1B ], IL6 , tumor necrosis factor-α-induced protein 3 [ TNFAIP3 ], TNF receptor superfamily member 1B [ TNFRSF1B ], vascular cell adhesion molecule-1 [ VCAM1 ]), (F) metabolism (ie, lipase H [ LIPH ], lymphatic vessel endothelial hyaluronan receptor 1 [ LYVE1 ], prostaglandin 2 [ PTGIS ], prostaglandin endoperoxide synthase 1 [ PTGS1 ], and Shisa family member 3 [ SHISA3 ]), (G) metabolism of proteins (ie, ADAM metallopeptidase with thrombospondin type 1 motif 18 [ ADAMTS18 ], pappalysin 1 [ PAPPA ], syndecan 2 [ SDC2 ], stanniocalcin 2 [ STC2 ], and transforming growth factor-β-induced [ TGFBI ]), and (H) cell cycle control (ie, cyclin A1 [ CCNA1 ], cyclin D2 [ CCND2 ], and cyclin-dependent kinase 6 [ CDK6 ]), as well as (I) playing a role in TGFβ signaling (ie, bone morphogenetic protein and activin membrane bound inhibitor [ BAMBI ], follistatin like protein 3 [ FSTL3 ], periostin [POSTN ], transforming growth factor-β1 [ TGFB1 ], and TGFB2 ). Quantitative data are presented as mean ± SEM. P values were determined with the use of Student’s t -test for normally distributed values ( ACTA2 , ADAMTS13 , DKK1 , F3 , FBN2 , LIPH , NID1 , PAI-1 , PTGIS , PTGS1 , POSTN , SDC2 , THBS2 , TFPI , TNFRSF1B , and VWF ) and Mann-Whitney U -test for values that did not pass the normality test ( ADAMTS18 , BAMBI , BIGH3 , CCL2 , CCNA1 , CCND2 , CD44 , CD62E , CD62P , CDK6 , COL1A1 , COL1A2 , COL3A1 , COL6A3 , CTSK , CTSS , CXCL6 , CXCL8 , FSTL3 , GATA3 , ICAM1 , IL1B , IL6 , LYVE1 , MMP1 , NOTCH3 , PAPPA , PROCR , SERPING1 , SHISA3 , STC2 , TAGLN , TGFB1 , TGFB2 , THBD , TNFAIP3 , TPA , and VCAM1 ) and are shown within the graph: ∗ P < 0.05; ns = nonsignificant. Data points in blue are from male patients, green from female patients.
Pulmonary Artery Endothelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Primary+Pulmonary+Artery%3B+Endothelial+Cells%3B+Normal%2C+Human/pmc03778740-59-19-25
Average 94 stars, based on 1 article reviews
pulmonary artery endothelial cells - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

96
Innoprot Inc human pulmonary microvascular endothelial cells hpmecs
Figure 1. (A,B) Effect of SSc and SSc iloprost-treated sera on human pulmonary <t>microvascular</t> <t>endothelial</t> cells <t>(HPMECs)</t> intracellular ROS levels. Before sera treatment, subconfluent HPMECs were loaded with 10 µM of H2-DCFDA, and then cultured in basal medium containing 10% (v/v) of sera from SSc patients (SSc), sera from iloprost-treated SSc patients (SSc + I),
Human Pulmonary Microvascular Endothelial Cells Hpmecs, supplied by Innoprot Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Human+Pulmonary+Microvascular+Endothelial+Cells/10__3390_slash_molecules26164729-88-3-19
Average 96 stars, based on 1 article reviews
human pulmonary microvascular endothelial cells hpmecs - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

91
PromoCell pulmonary artery endothelial cells
(A) Tree dendrogram depicting the relationship between human reference Whole Genome Bisulfite Sequencing (WGBS) datasets included in the analysis. Methylation status of the top 30,000 variable blocks was used as input for the unsupervised hierarchical clustering. Samples from cell types with greater than n=3 replicates were merged. (B) UMAP projection of human WGBS reference datasets, colored by tissue and cell-type. (C) UMAP projection of mouse WGBS reference datasets, colored by tissue and cell type. *Acronyms: CAEC = coronary artery <t>endothelial</t> cell, CMEC = cardiac microvascular endothelial cell, CPEC = joint cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, MK = megakaryocyte, NK = natural killer cell, PAEC = pulmonary artery endothelial cell, PMEC = pulmonary microvascular endothelial cell.
Pulmonary Artery Endothelial Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Human+Pulmonary+Artery+Endothelial+Cells+(HPAEC)%2C+Cell+Pellet+in+RNAlater/bio_rxiv__2022__04__12__487966-43-13-29
Average 91 stars, based on 1 article reviews
pulmonary artery endothelial cells - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
PromoCell human pulmonary microvasculature endothelial cells hpmecs
(A) Tree dendrogram depicting the relationship between human reference Whole Genome Bisulfite Sequencing (WGBS) datasets included in the analysis. Methylation status of the top 30,000 variable blocks was used as input for the unsupervised hierarchical clustering. Samples from cell types with greater than n=3 replicates were merged. (B) UMAP projection of human WGBS reference datasets, colored by tissue and cell-type. (C) UMAP projection of mouse WGBS reference datasets, colored by tissue and cell type. *Acronyms: CAEC = coronary artery <t>endothelial</t> cell, CMEC = cardiac microvascular endothelial cell, CPEC = joint cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, MK = megakaryocyte, NK = natural killer cell, PAEC = pulmonary artery endothelial cell, PMEC = pulmonary microvascular endothelial cell.
Human Pulmonary Microvasculature Endothelial Cells Hpmecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Human+Pulmonary+Microvascular+Endothelial+Cells+(HPMEC)%2C+Cell+Pellet+in+RNAlater/pmc07136287-60-0-12
Average 90 stars, based on 1 article reviews
human pulmonary microvasculature endothelial cells hpmecs - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

95
Cell Applications Inc human pulmonary artery endothelial cells paecs
(A) Tree dendrogram depicting the relationship between human reference Whole Genome Bisulfite Sequencing (WGBS) datasets included in the analysis. Methylation status of the top 30,000 variable blocks was used as input for the unsupervised hierarchical clustering. Samples from cell types with greater than n=3 replicates were merged. (B) UMAP projection of human WGBS reference datasets, colored by tissue and cell-type. (C) UMAP projection of mouse WGBS reference datasets, colored by tissue and cell type. *Acronyms: CAEC = coronary artery <t>endothelial</t> cell, CMEC = cardiac microvascular endothelial cell, CPEC = joint cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, MK = megakaryocyte, NK = natural killer cell, PAEC = pulmonary artery endothelial cell, PMEC = pulmonary microvascular endothelial cell.
Human Pulmonary Artery Endothelial Cells Paecs, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Human+Pulmonary+Artery+Endothelial+Cells%3A+HPAEC/pmc04628985-217-0-30
Average 95 stars, based on 1 article reviews
human pulmonary artery endothelial cells paecs - by Bioz Stars, 2026-11
95/100 stars
  Buy from Supplier

93
Angio-Proteomie human pulmonary lymphatic microvascular endothelial cells
(A) Tree dendrogram depicting the relationship between human reference Whole Genome Bisulfite Sequencing (WGBS) datasets included in the analysis. Methylation status of the top 30,000 variable blocks was used as input for the unsupervised hierarchical clustering. Samples from cell types with greater than n=3 replicates were merged. (B) UMAP projection of human WGBS reference datasets, colored by tissue and cell-type. (C) UMAP projection of mouse WGBS reference datasets, colored by tissue and cell type. *Acronyms: CAEC = coronary artery <t>endothelial</t> cell, CMEC = cardiac microvascular endothelial cell, CPEC = joint cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, MK = megakaryocyte, NK = natural killer cell, PAEC = pulmonary artery endothelial cell, PMEC = pulmonary microvascular endothelial cell.
Human Pulmonary Lymphatic Microvascular Endothelial Cells, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Human+Pulmonary+Lymphatic+Microvascular+Endothelial+Cells/bio_rxiv__2023__06__12__544372-149-10-22
Average 93 stars, based on 1 article reviews
human pulmonary lymphatic microvascular endothelial cells - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Angio-Proteomie cell applications
(A) Tree dendrogram depicting the relationship between human reference Whole Genome Bisulfite Sequencing (WGBS) datasets included in the analysis. Methylation status of the top 30,000 variable blocks was used as input for the unsupervised hierarchical clustering. Samples from cell types with greater than n=3 replicates were merged. (B) UMAP projection of human WGBS reference datasets, colored by tissue and cell-type. (C) UMAP projection of mouse WGBS reference datasets, colored by tissue and cell type. *Acronyms: CAEC = coronary artery <t>endothelial</t> cell, CMEC = cardiac microvascular endothelial cell, CPEC = joint cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, MK = megakaryocyte, NK = natural killer cell, PAEC = pulmonary artery endothelial cell, PMEC = pulmonary microvascular endothelial cell.
Cell Applications, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/Human+Pulmonary+Microvascular+Endothelial+Cells/pmc11211333-372-9-17
Average 92 stars, based on 1 article reviews
cell applications - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
ScienCell primary human pulmonary micro-vascular endothelial cells (hpmecs)
LPS induces GSK-3beta activation in dose- and time-dependent manners in <t>HPMECs.</t> Expression of P-GSK-3beta and GSK-3beta was detected after incubation with different concentrations of LPS for 1 h (A) . The expression of P-GSK-3beta was represented as a histogram according to band intensities (B) . Expression of P-GSK-3beta and GSK-3beta was examined at indicated time points after stimulation with LPS (0.1 μg/ml) in HPMECs (C) . The Western blotting results are presented as a histogram showing the band intensity values (D) . * P < 0.05 vs. LPS un-treatment group.
Primary Human Pulmonary Micro Vascular Endothelial Cells (Hpmecs), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/human+pulmonary+microvascular+endothelial+cells++hpmecs+/pmc05543036-47-0-9
Average 90 stars, based on 1 article reviews
primary human pulmonary micro-vascular endothelial cells (hpmecs) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ScienCell human pulmonary artery endothelial cells (paecs)
LPS induces GSK-3beta activation in dose- and time-dependent manners in <t>HPMECs.</t> Expression of P-GSK-3beta and GSK-3beta was detected after incubation with different concentrations of LPS for 1 h (A) . The expression of P-GSK-3beta was represented as a histogram according to band intensities (B) . Expression of P-GSK-3beta and GSK-3beta was examined at indicated time points after stimulation with LPS (0.1 μg/ml) in HPMECs (C) . The Western blotting results are presented as a histogram showing the band intensity values (D) . * P < 0.05 vs. LPS un-treatment group.
Human Pulmonary Artery Endothelial Cells (Paecs), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/Human+Pulmonary+Endothelial+Cells/human+pulmonary+artery+endothelial+cells/pm27084848-63-0-6
Average 90 stars, based on 1 article reviews
human pulmonary artery endothelial cells (paecs) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Figure 4. EndT and EndMT of Metastatic Melanoma Cells in Mouse (A) Whole-mount staining of pulmonary artery with GFP+ cells located at the endothelium (Videos S1, S2, and S3). Bars: 10 mm. (B and C) EndT occurred in lymph nodes. EndT occurred in LYVE-1+ lymphatic vessles (B) and CD31+ blood vessels (C) in lymph nodes. Bars: 20 mm. (D) LYVE-1 immunostaining on lung cryosections. Bar: 20 mm. (E–J) Immunostaining indicated EndT is transient during tumor progression. At primary tumor sites, GFP+ cells were CD31-, VE-cadherin+ (E and H), while in the lung blood vessels, GFP+ cells were both CD31+ and VE-cadherin+ (F and I). GFP+ cells lost both endothelial markers when populating metastases in the lung (G and J). Bars: 20 mm. (K) CD31+/a-SMA+/GFP+ cell (arrowhead) inside the alveolar capillary. CD31+/aSMA+/GFP cell (arrow) near the GFP+ cell showed the same phenotype. It is possible that this is an authentic vascular endothelial cell undergoing EndMT or a metastatic cell that was not labeled with GFP. Bars: 10 mm. (A–K) Mice, n R 3. (L) Correlation between the number of GFP+ cells per vessel and the number of metastasis foci or the size of metastasis foci per mouse. The number of GFP+ cells/vessel vs. number of metastasis foci, r = 0.7950, p = 0.03*; number of GFP+ cells/vessel vs. metastasis size, r = 0.8012, *p = 0.03. Mice, n = 7.

Journal: Cell reports

Article Title: Disseminated Melanoma Cells Transdifferentiate into Endothelial Cells in Intravascular Niches at Metastatic Sites.

doi: 10.1016/j.celrep.2020.107765

Figure Lengend Snippet: Figure 4. EndT and EndMT of Metastatic Melanoma Cells in Mouse (A) Whole-mount staining of pulmonary artery with GFP+ cells located at the endothelium (Videos S1, S2, and S3). Bars: 10 mm. (B and C) EndT occurred in lymph nodes. EndT occurred in LYVE-1+ lymphatic vessles (B) and CD31+ blood vessels (C) in lymph nodes. Bars: 20 mm. (D) LYVE-1 immunostaining on lung cryosections. Bar: 20 mm. (E–J) Immunostaining indicated EndT is transient during tumor progression. At primary tumor sites, GFP+ cells were CD31-, VE-cadherin+ (E and H), while in the lung blood vessels, GFP+ cells were both CD31+ and VE-cadherin+ (F and I). GFP+ cells lost both endothelial markers when populating metastases in the lung (G and J). Bars: 20 mm. (K) CD31+/a-SMA+/GFP+ cell (arrowhead) inside the alveolar capillary. CD31+/aSMA+/GFP cell (arrow) near the GFP+ cell showed the same phenotype. It is possible that this is an authentic vascular endothelial cell undergoing EndMT or a metastatic cell that was not labeled with GFP. Bars: 10 mm. (A–K) Mice, n R 3. (L) Correlation between the number of GFP+ cells per vessel and the number of metastasis foci or the size of metastasis foci per mouse. The number of GFP+ cells/vessel vs. number of metastasis foci, r = 0.7950, p = 0.03*; number of GFP+ cells/vessel vs. metastasis size, r = 0.8012, *p = 0.03. Mice, n = 7.

Article Snippet: Human pulmonary artery endothelial cells (PAECs; ATCC PCS-100-022) were cultured according to the supplier’s instructions.

Techniques: Staining, Immunostaining, Labeling

Figure 5. In Vitro System of Melanoma Cell EndT (A–C) Melanoma/endothelial marker immunostaining of Q-YUWERA cells (cells with green dots) cultured alone (A, VE-cadherin showed background staining in nuclei) or 5 days after co-culturing with PAECs (B and C). CD31 and HMB45 double staining in (B), VE-cadherin and HMB45 double staining in (C). Bars: 20 mm. Independent experiments, n R 3. (D) Imaging flow cytometry confirmed the expression of CD31 by individual YUWERA (APC+) cells after the co-culture. BF, bright field; SSC, side scatter; APC, CellTrace far red-labeled YUWERA cells. (E) YUWERA cells were labeled with a CFSE proliferation kit and co-cultured with PAECs for 5 days with 300 nM sunitinib treatment or control solution. Cells were subjected to CD31 staining followed by flow cytometry analysis. Independent experiments, n = 3; replicates, n = 3 in each experiment. 300 nM sunitinib treatment significantly increased the percentage of CD31+ YUWERA cells of the overall YUWERA cells in the co-culture (control group 2.878% ± 0.1309%, sunitinib group 4.677% ± 0.3125%,*p = 0.0357, shown as mean ± SEM by a Mann-Whitney test).

Journal: Cell reports

Article Title: Disseminated Melanoma Cells Transdifferentiate into Endothelial Cells in Intravascular Niches at Metastatic Sites.

doi: 10.1016/j.celrep.2020.107765

Figure Lengend Snippet: Figure 5. In Vitro System of Melanoma Cell EndT (A–C) Melanoma/endothelial marker immunostaining of Q-YUWERA cells (cells with green dots) cultured alone (A, VE-cadherin showed background staining in nuclei) or 5 days after co-culturing with PAECs (B and C). CD31 and HMB45 double staining in (B), VE-cadherin and HMB45 double staining in (C). Bars: 20 mm. Independent experiments, n R 3. (D) Imaging flow cytometry confirmed the expression of CD31 by individual YUWERA (APC+) cells after the co-culture. BF, bright field; SSC, side scatter; APC, CellTrace far red-labeled YUWERA cells. (E) YUWERA cells were labeled with a CFSE proliferation kit and co-cultured with PAECs for 5 days with 300 nM sunitinib treatment or control solution. Cells were subjected to CD31 staining followed by flow cytometry analysis. Independent experiments, n = 3; replicates, n = 3 in each experiment. 300 nM sunitinib treatment significantly increased the percentage of CD31+ YUWERA cells of the overall YUWERA cells in the co-culture (control group 2.878% ± 0.1309%, sunitinib group 4.677% ± 0.3125%,*p = 0.0357, shown as mean ± SEM by a Mann-Whitney test).

Article Snippet: Human pulmonary artery endothelial cells (PAECs; ATCC PCS-100-022) were cultured according to the supplier’s instructions.

Techniques: In Vitro, Marker, Immunostaining, Cell Culture, Staining, Double Staining, Imaging, Cytometry, Expressing, Co-Culture Assay, Labeling, Control, MANN-WHITNEY

Figure 6. EndT Inferred from Single-Cell RNA-Seq Data and Immunofluorescence in Metastatic Human Melanoma Biopsies (A) tSNE plot from single-cell RNA-seq showing metastatic melanoma cells of different patients (23). Malignant melanoma cells were selected based on aberrant copy number profiles, which are mutually exclusive from authentic endothelial cells, and plotted based on their pigmentation activity score, based on AUCell (37). The zoom shows cells of a melanoma patient that does not show pigmentation activity but had rare cells with high expressional activity for an endothelial gene signature. (B–I) Immunofluorescence on metastatic melanoma biopsies from BRAFV600E-harboring patients. (B and C) Representative double-immunofluorescence mi- crographs for BRAFV600E and CD31 of metastatic melanoma biopsies in the lung (B) and in the brain (C). (D and E) BRAFV600E+/CD31+ cells (arrows) localized inside the vasculature of metastatic melanoma biopsies in the lung (D) and in the brain (E). Bars: 50 mm. (F and G) Representative triple-immunofluorescence micrographs for BRAFV600E, MITF and CD31 of metastatic melanoma biopsies in the lung F) and in the brain (G). (H and I) BRAFV600E+/CD31+ cells inside the vasculature of metastatic melanoma biopsies in the lung (H) and in the brain (I) were negative for melanocytic marker MITF (arrows). Bars: 50 mm.

Journal: Cell reports

Article Title: Disseminated Melanoma Cells Transdifferentiate into Endothelial Cells in Intravascular Niches at Metastatic Sites.

doi: 10.1016/j.celrep.2020.107765

Figure Lengend Snippet: Figure 6. EndT Inferred from Single-Cell RNA-Seq Data and Immunofluorescence in Metastatic Human Melanoma Biopsies (A) tSNE plot from single-cell RNA-seq showing metastatic melanoma cells of different patients (23). Malignant melanoma cells were selected based on aberrant copy number profiles, which are mutually exclusive from authentic endothelial cells, and plotted based on their pigmentation activity score, based on AUCell (37). The zoom shows cells of a melanoma patient that does not show pigmentation activity but had rare cells with high expressional activity for an endothelial gene signature. (B–I) Immunofluorescence on metastatic melanoma biopsies from BRAFV600E-harboring patients. (B and C) Representative double-immunofluorescence mi- crographs for BRAFV600E and CD31 of metastatic melanoma biopsies in the lung (B) and in the brain (C). (D and E) BRAFV600E+/CD31+ cells (arrows) localized inside the vasculature of metastatic melanoma biopsies in the lung (D) and in the brain (E). Bars: 50 mm. (F and G) Representative triple-immunofluorescence micrographs for BRAFV600E, MITF and CD31 of metastatic melanoma biopsies in the lung F) and in the brain (G). (H and I) BRAFV600E+/CD31+ cells inside the vasculature of metastatic melanoma biopsies in the lung (H) and in the brain (I) were negative for melanocytic marker MITF (arrows). Bars: 50 mm.

Article Snippet: Human pulmonary artery endothelial cells (PAECs; ATCC PCS-100-022) were cultured according to the supplier’s instructions.

Techniques: RNA Sequencing, Activity Assay, Marker

FIGURE 2 | High physiological shear stress induces most prominently iRhom1 in endothelial cells from different vascular beds. HUVECs, HUAECs, HAMECs, and HPMECs were cultured for 24 h with a laminar shear stress of 30 dyn/cm2. Cells were then analyzed for mRNA expression of KLF2 (A), NOS3 (B), RHBDF1 (C), RHBDF2 (D), ADAM17 (E), and ADAM10 (F) in relation to a reference gene index consisting of GAPDH and TBP. The three independent experiments were performed with HUVECs and HUAECs from three different donors and HAMECs and HPMECs from two different donors. Data are shown as mean + standard deviation (SD) and as black and gray dots representing the individual data points. Statistical differences to the static control are indicated by asterisks (*p < 0.05, **p < 0.01, and ***p < 0.001). Significant differences between the different endothelial cell types were marked with different letters (a, b, c, and d). Each group with one letter is significantly different from a group with another letter.

Journal: Frontiers in cardiovascular medicine

Article Title: Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells.

doi: 10.3389/fcvm.2020.610344

Figure Lengend Snippet: FIGURE 2 | High physiological shear stress induces most prominently iRhom1 in endothelial cells from different vascular beds. HUVECs, HUAECs, HAMECs, and HPMECs were cultured for 24 h with a laminar shear stress of 30 dyn/cm2. Cells were then analyzed for mRNA expression of KLF2 (A), NOS3 (B), RHBDF1 (C), RHBDF2 (D), ADAM17 (E), and ADAM10 (F) in relation to a reference gene index consisting of GAPDH and TBP. The three independent experiments were performed with HUVECs and HUAECs from three different donors and HAMECs and HPMECs from two different donors. Data are shown as mean + standard deviation (SD) and as black and gray dots representing the individual data points. Statistical differences to the static control are indicated by asterisks (*p < 0.05, **p < 0.01, and ***p < 0.001). Significant differences between the different endothelial cell types were marked with different letters (a, b, c, and d). Each group with one letter is significantly different from a group with another letter.

Article Snippet: Human pulmonary microvascular endothelial cells (HPMECs) were from Promocell (Heidelberg, Germany).

Techniques: Shear, Cell Culture, Expressing, Standard Deviation, Control

Validation of Selected Genes With the Use of RT 2 Profiler PCR Array and qPCR Analysis (A) Schematic representation of the experimental flow, including the cultivation of chronic thromboembolic pulmonary hypertension (CTEPH) endothelial cells (ECs) from pulmonary endarterectomy (PEA) specimens and preparation for further analysis. (B to I) Real-time qPCR analysis (using custom-designed RT 2 Profiler PCR assay or qPCR with custom oligonucleotides) of CTEPH-ECs (7 biological repeats) compared with human pulmonary arterial endothelial cells (HPAECs) (3 biological repeats) for genes (B) involved in extracellular matrix organization (ie, CD44 molecule [ CD44 ], collagen type 1 alpha 1 chain - ( COL1A1 ), collagen type 1 alpha 2 chain [ COL1A2 ], collagen type 3 alpha 1 chain [ COL3A1 ], collagen type 6 alpha 3 chain [ COL6A3 ], fibrillin 2 [ FBN2 ], matrix metalloproteinase 1 [ MMP1 ], and nidogen 1 [ NID1 ]) or belonging to the biological pathways (C) hemostasis (ie, ADAM metallopeptidase with thrombospondin type 1 motif 13 [ ADAMTS13 ], C-X-C motif chemokine ligand 8 [ CXCL8 or IL8 ], selectin E [ CD62E ], selectin P [ CD62P ], endothelial protein C receptor [ PROCR ], coagulation factor III [ F3 ], plasminogen activator inhibitor-1 [ PAI-1 ], serpin family G member 1 [ SERPING1 ], von Willebrand factor [ VWF ], transgelin [ TAGLN ], tissue factor pathway inhibitor [ TFPI ], tissue-type plasminogen activator [ TPA ], and thrombomodulin [ THBD ]), (D) signal transduction (ie, smooth muscle α-actin [ ACTA2 ], chemokine C-X-C motif ligand 6 [ CXCL6 ], Dickkopf-related protein 1 [ DKK1 ], Gata-binding protein 3 [ GATA3 ], neurogenic locus Notch homolog protein 3 [ NOTCH3 ], and thrombospondin [ THBS2 ]), (E) immune system (ie, C-C motif chemokine ligand 2 [ CCL2 ], cathepsin K [ CTSK ], cathepsin S [ CTSS ], intercellular adhesion molecule-1 [ ICAM1 ], interleukin-1β [ IL1B ], IL6 , tumor necrosis factor-α-induced protein 3 [ TNFAIP3 ], TNF receptor superfamily member 1B [ TNFRSF1B ], vascular cell adhesion molecule-1 [ VCAM1 ]), (F) metabolism (ie, lipase H [ LIPH ], lymphatic vessel endothelial hyaluronan receptor 1 [ LYVE1 ], prostaglandin 2 [ PTGIS ], prostaglandin endoperoxide synthase 1 [ PTGS1 ], and Shisa family member 3 [ SHISA3 ]), (G) metabolism of proteins (ie, ADAM metallopeptidase with thrombospondin type 1 motif 18 [ ADAMTS18 ], pappalysin 1 [ PAPPA ], syndecan 2 [ SDC2 ], stanniocalcin 2 [ STC2 ], and transforming growth factor-β-induced [ TGFBI ]), and (H) cell cycle control (ie, cyclin A1 [ CCNA1 ], cyclin D2 [ CCND2 ], and cyclin-dependent kinase 6 [ CDK6 ]), as well as (I) playing a role in TGFβ signaling (ie, bone morphogenetic protein and activin membrane bound inhibitor [ BAMBI ], follistatin like protein 3 [ FSTL3 ], periostin [POSTN ], transforming growth factor-β1 [ TGFB1 ], and TGFB2 ). Quantitative data are presented as mean ± SEM. P values were determined with the use of Student’s t -test for normally distributed values ( ACTA2 , ADAMTS13 , DKK1 , F3 , FBN2 , LIPH , NID1 , PAI-1 , PTGIS , PTGS1 , POSTN , SDC2 , THBS2 , TFPI , TNFRSF1B , and VWF ) and Mann-Whitney U -test for values that did not pass the normality test ( ADAMTS18 , BAMBI , BIGH3 , CCL2 , CCNA1 , CCND2 , CD44 , CD62E , CD62P , CDK6 , COL1A1 , COL1A2 , COL3A1 , COL6A3 , CTSK , CTSS , CXCL6 , CXCL8 , FSTL3 , GATA3 , ICAM1 , IL1B , IL6 , LYVE1 , MMP1 , NOTCH3 , PAPPA , PROCR , SERPING1 , SHISA3 , STC2 , TAGLN , TGFB1 , TGFB2 , THBD , TNFAIP3 , TPA , and VCAM1 ) and are shown within the graph: ∗ P < 0.05; ns = nonsignificant. Data points in blue are from male patients, green from female patients.

Journal: JACC: Basic to Translational Science

Article Title: Endothelial Overexpression of TGF-β-Induced Protein Impairs Venous Thrombus Resolution

doi: 10.1016/j.jacbts.2023.08.005

Figure Lengend Snippet: Validation of Selected Genes With the Use of RT 2 Profiler PCR Array and qPCR Analysis (A) Schematic representation of the experimental flow, including the cultivation of chronic thromboembolic pulmonary hypertension (CTEPH) endothelial cells (ECs) from pulmonary endarterectomy (PEA) specimens and preparation for further analysis. (B to I) Real-time qPCR analysis (using custom-designed RT 2 Profiler PCR assay or qPCR with custom oligonucleotides) of CTEPH-ECs (7 biological repeats) compared with human pulmonary arterial endothelial cells (HPAECs) (3 biological repeats) for genes (B) involved in extracellular matrix organization (ie, CD44 molecule [ CD44 ], collagen type 1 alpha 1 chain - ( COL1A1 ), collagen type 1 alpha 2 chain [ COL1A2 ], collagen type 3 alpha 1 chain [ COL3A1 ], collagen type 6 alpha 3 chain [ COL6A3 ], fibrillin 2 [ FBN2 ], matrix metalloproteinase 1 [ MMP1 ], and nidogen 1 [ NID1 ]) or belonging to the biological pathways (C) hemostasis (ie, ADAM metallopeptidase with thrombospondin type 1 motif 13 [ ADAMTS13 ], C-X-C motif chemokine ligand 8 [ CXCL8 or IL8 ], selectin E [ CD62E ], selectin P [ CD62P ], endothelial protein C receptor [ PROCR ], coagulation factor III [ F3 ], plasminogen activator inhibitor-1 [ PAI-1 ], serpin family G member 1 [ SERPING1 ], von Willebrand factor [ VWF ], transgelin [ TAGLN ], tissue factor pathway inhibitor [ TFPI ], tissue-type plasminogen activator [ TPA ], and thrombomodulin [ THBD ]), (D) signal transduction (ie, smooth muscle α-actin [ ACTA2 ], chemokine C-X-C motif ligand 6 [ CXCL6 ], Dickkopf-related protein 1 [ DKK1 ], Gata-binding protein 3 [ GATA3 ], neurogenic locus Notch homolog protein 3 [ NOTCH3 ], and thrombospondin [ THBS2 ]), (E) immune system (ie, C-C motif chemokine ligand 2 [ CCL2 ], cathepsin K [ CTSK ], cathepsin S [ CTSS ], intercellular adhesion molecule-1 [ ICAM1 ], interleukin-1β [ IL1B ], IL6 , tumor necrosis factor-α-induced protein 3 [ TNFAIP3 ], TNF receptor superfamily member 1B [ TNFRSF1B ], vascular cell adhesion molecule-1 [ VCAM1 ]), (F) metabolism (ie, lipase H [ LIPH ], lymphatic vessel endothelial hyaluronan receptor 1 [ LYVE1 ], prostaglandin 2 [ PTGIS ], prostaglandin endoperoxide synthase 1 [ PTGS1 ], and Shisa family member 3 [ SHISA3 ]), (G) metabolism of proteins (ie, ADAM metallopeptidase with thrombospondin type 1 motif 18 [ ADAMTS18 ], pappalysin 1 [ PAPPA ], syndecan 2 [ SDC2 ], stanniocalcin 2 [ STC2 ], and transforming growth factor-β-induced [ TGFBI ]), and (H) cell cycle control (ie, cyclin A1 [ CCNA1 ], cyclin D2 [ CCND2 ], and cyclin-dependent kinase 6 [ CDK6 ]), as well as (I) playing a role in TGFβ signaling (ie, bone morphogenetic protein and activin membrane bound inhibitor [ BAMBI ], follistatin like protein 3 [ FSTL3 ], periostin [POSTN ], transforming growth factor-β1 [ TGFB1 ], and TGFB2 ). Quantitative data are presented as mean ± SEM. P values were determined with the use of Student’s t -test for normally distributed values ( ACTA2 , ADAMTS13 , DKK1 , F3 , FBN2 , LIPH , NID1 , PAI-1 , PTGIS , PTGS1 , POSTN , SDC2 , THBS2 , TFPI , TNFRSF1B , and VWF ) and Mann-Whitney U -test for values that did not pass the normality test ( ADAMTS18 , BAMBI , BIGH3 , CCL2 , CCNA1 , CCND2 , CD44 , CD62E , CD62P , CDK6 , COL1A1 , COL1A2 , COL3A1 , COL6A3 , CTSK , CTSS , CXCL6 , CXCL8 , FSTL3 , GATA3 , ICAM1 , IL1B , IL6 , LYVE1 , MMP1 , NOTCH3 , PAPPA , PROCR , SERPING1 , SHISA3 , STC2 , TAGLN , TGFB1 , TGFB2 , THBD , TNFAIP3 , TPA , and VCAM1 ) and are shown within the graph: ∗ P < 0.05; ns = nonsignificant. Data points in blue are from male patients, green from female patients.

Article Snippet: CTEPH-ECs (passage 3) were compared with human pulmonary artery endothelial cells (HPAECs) (PromoCell and ATCC), cultivated in Endothelial Cell Growth Medium MV2 Kit (PromoCell).

Techniques: Biomarker Discovery, Coagulation, Transduction, Binding Assay, Control, Membrane, MANN-WHITNEY

Overexpression of TGFBI in HPAECs Promotes the Expression of Genes Similar to CTEPH-ECs and Results in Larger Human Blood Clots (A) Representative immunofluorescence images and (B) quantitative analysis of the mean fluorescent intensity of HPAECs in culture after treatment with control lentiviral particles (lentiviral control) or lentiviral particles containing human TGFBI (TGFBI lentiviral particles) and immunostaining for TGFBI (red) and DAPI (blue). Quantitative data are presented as mean ± SEM. ∗∗∗ P < 0.001 (Student’s t -test). Scale bars represent 10 μm. (C) Quantitative RT 2 Profiler PCR array analysis confirmed significantly increased expression of TGFBI and also revealed significant changes of genes belonging to the biological pathways signal transduction ( ACTA2 ), metabolism of proteins ( STC2 ), cell cycle control ( CCND2 ), hemostasi’ ( TAGLN ), and metabolism ( PTGIS ) and genes involved in TGFβ signaling ( FSTL3 ) and extracellular matrix organization ( COL1A1 ) in HPAECs overexpressing TGFBI (n = 3 experimental repeats; female donor). Data are expressed as fold change vs lentiviral control cells. Quantitative data are presented as mean ± SEM. ∗ P < 0.05; ∗∗ P < 0.01; ∗∗∗ P < 0.001 (Student’s t -test). (D) Weight of blood clots generated in vitro followed by addition of HPAECs expressing lentiviral TGFBI or control and incubation for 14 days (n = 3 biological repeats and 2 experimental repeats). Quantitative data are presented as mean ± SEM. ∗ P < 0.05 (Student’s t -test). (E and G) Representative immunohistochemical images of human blood clots after immunostaining of the endothelial marker VE-cadherin (CDH5) and the results of the quantitative analysis of the total vessel area after addition of HPAECs (F) overexpressing TGFBI or (H) stimulated with recombinant TGFBI. Scale bars represent 10 μm. Quantitative data are presented as mean ± SEM. ∗ P < 0.05; ∗∗∗ P < 0.001 (Student’s t -test). (I) Representative immunohistochemical images and (J) results of the quantitative analysis of human blood clots mixed with human ECs overexpressing lentiviral TGFBI or control after immunostaining of the mesenchymal marker smooth muscle actin (SMA). Scale bars represent 10 μm. Quantitative data are presented as mean ± SEM. ∗∗ P < 0.01 (Student’s t -test). Real-time qPCR analysis to detect the transcription factors (K) SNAI2 , (L) TWIST , and (M) ZEB1 in HPAECs overexpressing TGFBI or in lentiviral control cells. Data were normalized to the housekeeping gene HPRT1. Quantitative data are presented as mean ± SEM and compared by means of Student’s t -test (K and M), or as median with IQR and compared by means of Mann-Whitney U -test (L). ∗ P < 0.05; ∗∗∗ P < 0.001; ns = nonsignificant. Abbreviations as in <xref ref-type=Figure 1 . " width="100%" height="100%">

Journal: JACC: Basic to Translational Science

Article Title: Endothelial Overexpression of TGF-β-Induced Protein Impairs Venous Thrombus Resolution

doi: 10.1016/j.jacbts.2023.08.005

Figure Lengend Snippet: Overexpression of TGFBI in HPAECs Promotes the Expression of Genes Similar to CTEPH-ECs and Results in Larger Human Blood Clots (A) Representative immunofluorescence images and (B) quantitative analysis of the mean fluorescent intensity of HPAECs in culture after treatment with control lentiviral particles (lentiviral control) or lentiviral particles containing human TGFBI (TGFBI lentiviral particles) and immunostaining for TGFBI (red) and DAPI (blue). Quantitative data are presented as mean ± SEM. ∗∗∗ P < 0.001 (Student’s t -test). Scale bars represent 10 μm. (C) Quantitative RT 2 Profiler PCR array analysis confirmed significantly increased expression of TGFBI and also revealed significant changes of genes belonging to the biological pathways signal transduction ( ACTA2 ), metabolism of proteins ( STC2 ), cell cycle control ( CCND2 ), hemostasi’ ( TAGLN ), and metabolism ( PTGIS ) and genes involved in TGFβ signaling ( FSTL3 ) and extracellular matrix organization ( COL1A1 ) in HPAECs overexpressing TGFBI (n = 3 experimental repeats; female donor). Data are expressed as fold change vs lentiviral control cells. Quantitative data are presented as mean ± SEM. ∗ P < 0.05; ∗∗ P < 0.01; ∗∗∗ P < 0.001 (Student’s t -test). (D) Weight of blood clots generated in vitro followed by addition of HPAECs expressing lentiviral TGFBI or control and incubation for 14 days (n = 3 biological repeats and 2 experimental repeats). Quantitative data are presented as mean ± SEM. ∗ P < 0.05 (Student’s t -test). (E and G) Representative immunohistochemical images of human blood clots after immunostaining of the endothelial marker VE-cadherin (CDH5) and the results of the quantitative analysis of the total vessel area after addition of HPAECs (F) overexpressing TGFBI or (H) stimulated with recombinant TGFBI. Scale bars represent 10 μm. Quantitative data are presented as mean ± SEM. ∗ P < 0.05; ∗∗∗ P < 0.001 (Student’s t -test). (I) Representative immunohistochemical images and (J) results of the quantitative analysis of human blood clots mixed with human ECs overexpressing lentiviral TGFBI or control after immunostaining of the mesenchymal marker smooth muscle actin (SMA). Scale bars represent 10 μm. Quantitative data are presented as mean ± SEM. ∗∗ P < 0.01 (Student’s t -test). Real-time qPCR analysis to detect the transcription factors (K) SNAI2 , (L) TWIST , and (M) ZEB1 in HPAECs overexpressing TGFBI or in lentiviral control cells. Data were normalized to the housekeeping gene HPRT1. Quantitative data are presented as mean ± SEM and compared by means of Student’s t -test (K and M), or as median with IQR and compared by means of Mann-Whitney U -test (L). ∗ P < 0.05; ∗∗∗ P < 0.001; ns = nonsignificant. Abbreviations as in Figure 1 .

Article Snippet: CTEPH-ECs (passage 3) were compared with human pulmonary artery endothelial cells (HPAECs) (PromoCell and ATCC), cultivated in Endothelial Cell Growth Medium MV2 Kit (PromoCell).

Techniques: Over Expression, Expressing, Immunofluorescence, Control, Immunostaining, Transduction, Generated, In Vitro, Incubation, Immunohistochemical staining, Marker, Recombinant, MANN-WHITNEY

Figure 1. (A,B) Effect of SSc and SSc iloprost-treated sera on human pulmonary microvascular endothelial cells (HPMECs) intracellular ROS levels. Before sera treatment, subconfluent HPMECs were loaded with 10 µM of H2-DCFDA, and then cultured in basal medium containing 10% (v/v) of sera from SSc patients (SSc), sera from iloprost-treated SSc patients (SSc + I),

Journal: Molecules

Article Title: Iloprost Attenuates Oxidative Stress-Dependent Activation of Collagen Synthesis Induced by Sera from Scleroderma Patients in Human Pulmonary Microvascular Endothelial Cells

doi: 10.3390/molecules26164729

Figure Lengend Snippet: Figure 1. (A,B) Effect of SSc and SSc iloprost-treated sera on human pulmonary microvascular endothelial cells (HPMECs) intracellular ROS levels. Before sera treatment, subconfluent HPMECs were loaded with 10 µM of H2-DCFDA, and then cultured in basal medium containing 10% (v/v) of sera from SSc patients (SSc), sera from iloprost-treated SSc patients (SSc + I),

Article Snippet: In this study, human pulmonary microvascular endothelial cells (HPMECs) isolated from the human lung of healthy donors were used (Innoprot, Bizkaia, Spain).

Techniques: Cell Culture

(A) Tree dendrogram depicting the relationship between human reference Whole Genome Bisulfite Sequencing (WGBS) datasets included in the analysis. Methylation status of the top 30,000 variable blocks was used as input for the unsupervised hierarchical clustering. Samples from cell types with greater than n=3 replicates were merged. (B) UMAP projection of human WGBS reference datasets, colored by tissue and cell-type. (C) UMAP projection of mouse WGBS reference datasets, colored by tissue and cell type. *Acronyms: CAEC = coronary artery endothelial cell, CMEC = cardiac microvascular endothelial cell, CPEC = joint cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, MK = megakaryocyte, NK = natural killer cell, PAEC = pulmonary artery endothelial cell, PMEC = pulmonary microvascular endothelial cell.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A) Tree dendrogram depicting the relationship between human reference Whole Genome Bisulfite Sequencing (WGBS) datasets included in the analysis. Methylation status of the top 30,000 variable blocks was used as input for the unsupervised hierarchical clustering. Samples from cell types with greater than n=3 replicates were merged. (B) UMAP projection of human WGBS reference datasets, colored by tissue and cell-type. (C) UMAP projection of mouse WGBS reference datasets, colored by tissue and cell type. *Acronyms: CAEC = coronary artery endothelial cell, CMEC = cardiac microvascular endothelial cell, CPEC = joint cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, MK = megakaryocyte, NK = natural killer cell, PAEC = pulmonary artery endothelial cell, PMEC = pulmonary microvascular endothelial cell.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Methylation Sequencing, Methylation

(A-B) Heatmaps of differentially methylated cell-type specific blocks identified from reference WGBS data compiled from healthy cell types and tissues in human (A) and mouse (B). Each cell in the plot marks the methylation score of one genomic region (rows) at each of the 20 cell types in human and 9 in mouse (columns). Up to 100 blocks with the highest methylation score are shown per cell type. The methylation score represents the number of fully unmethylated or methylated read-pairs / total coverage for hypo- and hyper-methylated blocks, respectively. (C) Heatmap of distance scores between gene-set pathways identified from GeneSetCluster. Genes adjacent to human cell-type specific methylation blocks were identified using HOMER and pathway analysis was performed using both Ingenuity Pathway Analysis (IPA) and GREAT. Significantly enriched gene-set pathways (p<0.05) from differentially methylated blocks identified in immune, cardiomyocyte, hepatocyte, and lung epithelial cell types were analyzed using GeneSetCluster. Cluster analysis was performed to determine the distance between all identified gene-set pathways based on the degree of overlapping genes from each individual gene-set compared to all others. Over-representation analysis was implemented in the WebgestaltR (ORAperGeneSet) plugin to interpret and functionally label identified gene-set clusters. *Acronyms: CPEC = cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, NK = natural killer cell.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A-B) Heatmaps of differentially methylated cell-type specific blocks identified from reference WGBS data compiled from healthy cell types and tissues in human (A) and mouse (B). Each cell in the plot marks the methylation score of one genomic region (rows) at each of the 20 cell types in human and 9 in mouse (columns). Up to 100 blocks with the highest methylation score are shown per cell type. The methylation score represents the number of fully unmethylated or methylated read-pairs / total coverage for hypo- and hyper-methylated blocks, respectively. (C) Heatmap of distance scores between gene-set pathways identified from GeneSetCluster. Genes adjacent to human cell-type specific methylation blocks were identified using HOMER and pathway analysis was performed using both Ingenuity Pathway Analysis (IPA) and GREAT. Significantly enriched gene-set pathways (p<0.05) from differentially methylated blocks identified in immune, cardiomyocyte, hepatocyte, and lung epithelial cell types were analyzed using GeneSetCluster. Cluster analysis was performed to determine the distance between all identified gene-set pathways based on the degree of overlapping genes from each individual gene-set compared to all others. Over-representation analysis was implemented in the WebgestaltR (ORAperGeneSet) plugin to interpret and functionally label identified gene-set clusters. *Acronyms: CPEC = cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, NK = natural killer cell.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Methylation

(A) Heatmap of distance scores between gene-set pathways identified from GeneSetCluster. Genes adjacent to cell-type specific methylation blocks were identified using HOMER and pathway analysis was performed using both Ingenuity Pathway Analysis (IPA) and GREAT. Significantly enriched gene-set pathways (p<0.05) from differentially methylated blocks identified in immune, cardiomyocyte, hepatocyte, and lung endothelial cell types were analyzed using GeneSetCluster. Cluster analysis was performed to determine the distance between all identified gene-set pathways based on the degree of overlapping genes from each individual gene-set compared to all others. Over-representation analysis was implemented in the WebgestaltR (ORAperGeneSet) plugin to interpret and functionally label identified gene-set clusters.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A) Heatmap of distance scores between gene-set pathways identified from GeneSetCluster. Genes adjacent to cell-type specific methylation blocks were identified using HOMER and pathway analysis was performed using both Ingenuity Pathway Analysis (IPA) and GREAT. Significantly enriched gene-set pathways (p<0.05) from differentially methylated blocks identified in immune, cardiomyocyte, hepatocyte, and lung endothelial cell types were analyzed using GeneSetCluster. Cluster analysis was performed to determine the distance between all identified gene-set pathways based on the degree of overlapping genes from each individual gene-set compared to all others. Over-representation analysis was implemented in the WebgestaltR (ORAperGeneSet) plugin to interpret and functionally label identified gene-set clusters.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Methylation

(A) Example of the NOS3 locus specifically unmethylated in endothelial cells. This endothelial-specific, differentially methylated block (DMB; highlighted in light blue) is 157bp long (7 CpGs), and is located within the NOS3 gene, an endothelial-specific gene (upregulated in paired RNA-sequencing data as well as in vascular endothelial cells, GTEx inset). The alignment from the UCSC genome browser (top) provides the genomic locus organization and is aligned with the average methylation (purple tracks) across cardiomyocyte, lung epithelial, liver sinusoidal endothelial (LSEC), cardiopulmonary endothelial (CPEC), hepatocyte, and immune (PBMC) samples (n=3 / cell-type group). Results from RNA-sequencing generated from paired cell-types are depicted (green tracks) as well as peak intensity from H3K27ac and H3K4me3 published ChIP-seq data generated in endothelial cells (blue tracks). (B) Significant functions of genes adjacent to endothelial-specific methylation blocks (all p<0.05). Blue color indicates nearby hypomethylated regulatory blocks. Yellow color indicates nearby hypermethylated regulatory blocks. (C) Pathways supporting the biological significance of endothelial-specific methylation blocks (all p<0.05). Unique pathways for distinct tissue-specific endothelial cells are highlighted in distinct colors. (D) Expression levels of genes adjacent to tissue-specific endothelial methylation blocks. Expression data were generated from paired RNA-sequencing of the same cardiopulmonary endothelial (CPEC) and liver sinusoidal endothelial (LSEC) cell populations used to generate methylation reference data. Pan-endothelial genes upregulated in both populations (ALL) are identified as common endothelial-specific methylation blocks to both LSEC and CPEC tissue-specific endothelial populations. (E) Top 5 transcription factor binding sites enriched among endothelial-specific hypomethylated blocks, using HOMER de novo and known motif analysis. The background for the HOMER analysis was composed of 3,574 non-endothelial cell-type specific hypomethylated blocks. *Acronyms: CPEC = cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A) Example of the NOS3 locus specifically unmethylated in endothelial cells. This endothelial-specific, differentially methylated block (DMB; highlighted in light blue) is 157bp long (7 CpGs), and is located within the NOS3 gene, an endothelial-specific gene (upregulated in paired RNA-sequencing data as well as in vascular endothelial cells, GTEx inset). The alignment from the UCSC genome browser (top) provides the genomic locus organization and is aligned with the average methylation (purple tracks) across cardiomyocyte, lung epithelial, liver sinusoidal endothelial (LSEC), cardiopulmonary endothelial (CPEC), hepatocyte, and immune (PBMC) samples (n=3 / cell-type group). Results from RNA-sequencing generated from paired cell-types are depicted (green tracks) as well as peak intensity from H3K27ac and H3K4me3 published ChIP-seq data generated in endothelial cells (blue tracks). (B) Significant functions of genes adjacent to endothelial-specific methylation blocks (all p<0.05). Blue color indicates nearby hypomethylated regulatory blocks. Yellow color indicates nearby hypermethylated regulatory blocks. (C) Pathways supporting the biological significance of endothelial-specific methylation blocks (all p<0.05). Unique pathways for distinct tissue-specific endothelial cells are highlighted in distinct colors. (D) Expression levels of genes adjacent to tissue-specific endothelial methylation blocks. Expression data were generated from paired RNA-sequencing of the same cardiopulmonary endothelial (CPEC) and liver sinusoidal endothelial (LSEC) cell populations used to generate methylation reference data. Pan-endothelial genes upregulated in both populations (ALL) are identified as common endothelial-specific methylation blocks to both LSEC and CPEC tissue-specific endothelial populations. (E) Top 5 transcription factor binding sites enriched among endothelial-specific hypomethylated blocks, using HOMER de novo and known motif analysis. The background for the HOMER analysis was composed of 3,574 non-endothelial cell-type specific hypomethylated blocks. *Acronyms: CPEC = cardio-pulmonary endothelial cell, HUVEV = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Methylation, Blocking Assay, RNA Sequencing, Generated, ChIP-sequencing, Expressing, Binding Assay

(A) Representative 3D-CRT treatment planning for patients with right-sided (i and ii) and left-sided (iii and iv) breast cancer, respectively. Computed tomography simulation of coronal and sagittal images depicting the anatomic position of the target volume in relation to nearby organs. The color map represents different radiation dose levels or isodose lines (Green: 95% of prescription dose, yellow: 90% isodose line, cyan: 80% isodose line, orange: 70% isodose line, brown: 50% isodose line). (B) Heatmaps of differentially methylated cell-type specific blocks identified from all reference WGBS data compiled from healthy human cell-types and tissues. Each cell in the plot marks the methylation score of one genomic region (rows) at each of the 20 human cell types (columns). Up to 100 blocks with the highest methylation score are shown per cell type. Differential blocks identified from cell types comprising the target organs-at-risk from radiation (lungs, heart, and liver) were selected for generation of a radiation-specific methylation atlas, separating these solid organ cell types from all other immune cell types. *Acronyms: CAEC = coronary artery endothelial cell, CMEC = cardiac microvascular endothelial cell, CPEC = joint cardio-pulmonary endothelial cell, HUVEC = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, MK = megakaryocyte, NK = natural killer cell, PAEC = pulmonary artery endothelial cell, PMEC = pulmonary microvascular endothelial cell.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A) Representative 3D-CRT treatment planning for patients with right-sided (i and ii) and left-sided (iii and iv) breast cancer, respectively. Computed tomography simulation of coronal and sagittal images depicting the anatomic position of the target volume in relation to nearby organs. The color map represents different radiation dose levels or isodose lines (Green: 95% of prescription dose, yellow: 90% isodose line, cyan: 80% isodose line, orange: 70% isodose line, brown: 50% isodose line). (B) Heatmaps of differentially methylated cell-type specific blocks identified from all reference WGBS data compiled from healthy human cell-types and tissues. Each cell in the plot marks the methylation score of one genomic region (rows) at each of the 20 human cell types (columns). Up to 100 blocks with the highest methylation score are shown per cell type. Differential blocks identified from cell types comprising the target organs-at-risk from radiation (lungs, heart, and liver) were selected for generation of a radiation-specific methylation atlas, separating these solid organ cell types from all other immune cell types. *Acronyms: CAEC = coronary artery endothelial cell, CMEC = cardiac microvascular endothelial cell, CPEC = joint cardio-pulmonary endothelial cell, HUVEC = human umbilical vein endothelial cell, LSEC = liver sinusoidal endothelial cell, MK = megakaryocyte, NK = natural killer cell, PAEC = pulmonary artery endothelial cell, PMEC = pulmonary microvascular endothelial cell.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Computed Tomography, Methylation

(A-D) (Left) Heatmap of all cell-type specific methylation blocks selected for each target cell type. All blocks contain 3+CpG sites and have a margin of beta difference greater than or equal to 0.35 separating the target cell type from all others included in the reference maps. All identified methylation blocks for lung endothelial (n=1,546), hepatocyte (n=616), and cardiomyocyte (n=2,917) mouse cell types were hypomethylated. In contrast, all identified immune cell-specific blocks (n=148) were hypermethylated relative to other solid organ cell types in mouse. (Right) In-silico mix-in validation of fragment-level probabilistic deconvolution model. Target cell-type read-pairs were in-silico mixed into a background of lymphocyte or buffy coat read-pairs at various known percentages (0, 0.5, 1, 2, 5, 10, 15%) with 10 replicates per proportion. The deconvolution model was validated on these in-silico mixed samples of known cell-type proportions at the blocks selected. The average predicted %target is graphed relative to the known %mixed to assess sensitivity and specificity of the identified cell-type specific blocks and deconvolution model. Reference WGBS samples with less than 3 replicates were split 0.8 train to select methylation blocks and 0.2 test to generate in-silico mixed samples. When available, in-silico mixed samples of the same cell-type derived from different aged mice were tested. In addition, bulk tissue of the respective cell type was tested as well.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A-D) (Left) Heatmap of all cell-type specific methylation blocks selected for each target cell type. All blocks contain 3+CpG sites and have a margin of beta difference greater than or equal to 0.35 separating the target cell type from all others included in the reference maps. All identified methylation blocks for lung endothelial (n=1,546), hepatocyte (n=616), and cardiomyocyte (n=2,917) mouse cell types were hypomethylated. In contrast, all identified immune cell-specific blocks (n=148) were hypermethylated relative to other solid organ cell types in mouse. (Right) In-silico mix-in validation of fragment-level probabilistic deconvolution model. Target cell-type read-pairs were in-silico mixed into a background of lymphocyte or buffy coat read-pairs at various known percentages (0, 0.5, 1, 2, 5, 10, 15%) with 10 replicates per proportion. The deconvolution model was validated on these in-silico mixed samples of known cell-type proportions at the blocks selected. The average predicted %target is graphed relative to the known %mixed to assess sensitivity and specificity of the identified cell-type specific blocks and deconvolution model. Reference WGBS samples with less than 3 replicates were split 0.8 train to select methylation blocks and 0.2 test to generate in-silico mixed samples. When available, in-silico mixed samples of the same cell-type derived from different aged mice were tested. In addition, bulk tissue of the respective cell type was tested as well.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Methylation, In Silico, Biomarker Discovery, Derivative Assay

(A) Representative H&E staining of lung, heart, and liver tissues from mice treated with 3Gy or 8Gy radiation compared to sham control. Scale bar, 200 µ m. (B) qPCR analysis of CDKN1A (p21) mRNA. The expression in each sample was normalized to ACTB and is shown relative to the expression in the sham control. Mean ± SD; N = 3. (C-F) Lung endothelial, cardiomyocyte and hepatocyte methylated cfDNA in the circulation of mice treated with 3Gy and 8Gy radiation compared to sham control expressed in Genome Equivalents (Geq). CfDNA was extracted from 18 mice (n=6 in each group) with cfDNA from 2 mice pooled in each methylome preparation. Mean ± SD; N = 3 independent methylome preparations. Kruskal-Wallis test was used for comparisons amongst groups. ns, P ≥ 0.05; *, P < 0.05.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A) Representative H&E staining of lung, heart, and liver tissues from mice treated with 3Gy or 8Gy radiation compared to sham control. Scale bar, 200 µ m. (B) qPCR analysis of CDKN1A (p21) mRNA. The expression in each sample was normalized to ACTB and is shown relative to the expression in the sham control. Mean ± SD; N = 3. (C-F) Lung endothelial, cardiomyocyte and hepatocyte methylated cfDNA in the circulation of mice treated with 3Gy and 8Gy radiation compared to sham control expressed in Genome Equivalents (Geq). CfDNA was extracted from 18 mice (n=6 in each group) with cfDNA from 2 mice pooled in each methylome preparation. Mean ± SD; N = 3 independent methylome preparations. Kruskal-Wallis test was used for comparisons amongst groups. ns, P ≥ 0.05; *, P < 0.05.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Staining, Control, Expressing, Methylation

(A-C Human) (A) Predicted human immune-derived cfDNA in Geq. Human Geq are calculated by multiplying the relative fraction of cell-type specific cfDNA x initial concentration cfDNA ng/mL x the weight of the haploid human genome. Immune cfDNA was assessed at n = 222 methylation blocks found to separate immune cell types from solid organ cell types. (g1 = Bcell, CD4Tcell, CD8Tcell, NK, MK, Erythroblast, Monocyte, Macrophage, Neutrophil; g2 = breast basal/luminal epi, lung epi, hepatocyte, kidney podocyte, pancreas islet, colon epi, cardiomyocyte, LSEC, CPEC, HUVEC, neuron, and skeletal muscle). (B) Predicted human solid organ-derived cfDNA in Geq where %solid organ is defined as 100-%immune using these same n=222 methylation blocks. (C) Fold change in human immune versus solid organ Geq at EOT and recovery relative to baseline. Friedman test was performed comparing paired results at baseline, EOT, and recovery timepoints. The results were considered significant when *P < 0.05. (D-E Mouse) (D) Predicted mouse immune-derived cfDNA in Geq. Mouse Geq are calculated by multiplying the relative fraction of cell-type specific cfDNA x initial concentration cfDNA ng/mL x the weight of the haploid mouse genome. Immune cfDNA was assessed at n = 148 methylation blocks found to separate immune cell types from solid organ cell types. (g1 = Bcell, CD4Tcell, CD8Tcell, Neutrophil; g2 = mammary epi, cardiomyocyte, hepatocyte, lung endothelial, cerebellum, hypothalamus, colon, intestine, kidney). (E) Predicted mouse solid organ-derived cfDNA in Geq. Kruskal-Wallis test was used for comparisons amongst groups. ns, P ≥ 0.05; *, P < 0.05.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A-C Human) (A) Predicted human immune-derived cfDNA in Geq. Human Geq are calculated by multiplying the relative fraction of cell-type specific cfDNA x initial concentration cfDNA ng/mL x the weight of the haploid human genome. Immune cfDNA was assessed at n = 222 methylation blocks found to separate immune cell types from solid organ cell types. (g1 = Bcell, CD4Tcell, CD8Tcell, NK, MK, Erythroblast, Monocyte, Macrophage, Neutrophil; g2 = breast basal/luminal epi, lung epi, hepatocyte, kidney podocyte, pancreas islet, colon epi, cardiomyocyte, LSEC, CPEC, HUVEC, neuron, and skeletal muscle). (B) Predicted human solid organ-derived cfDNA in Geq where %solid organ is defined as 100-%immune using these same n=222 methylation blocks. (C) Fold change in human immune versus solid organ Geq at EOT and recovery relative to baseline. Friedman test was performed comparing paired results at baseline, EOT, and recovery timepoints. The results were considered significant when *P < 0.05. (D-E Mouse) (D) Predicted mouse immune-derived cfDNA in Geq. Mouse Geq are calculated by multiplying the relative fraction of cell-type specific cfDNA x initial concentration cfDNA ng/mL x the weight of the haploid mouse genome. Immune cfDNA was assessed at n = 148 methylation blocks found to separate immune cell types from solid organ cell types. (g1 = Bcell, CD4Tcell, CD8Tcell, Neutrophil; g2 = mammary epi, cardiomyocyte, hepatocyte, lung endothelial, cerebellum, hypothalamus, colon, intestine, kidney). (E) Predicted mouse solid organ-derived cfDNA in Geq. Kruskal-Wallis test was used for comparisons amongst groups. ns, P ≥ 0.05; *, P < 0.05.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Derivative Assay, Concentration Assay, Methylation

(A, B) Hepatocyte cfDNA (in Geq/mL) in serum samples collected at different times. Fragment-level deconvolution used hepatocyte specific methylation blocks (top n=200). (C) Fold change in hepatocyte cfDNA after treatment (EOT) and at recovery relative to baseline. (D, E) Liver sinusoidal endothelial (LSEC) cfDNA (in Geq/mL) in the same serum samples. Fragment-level deconvolution used LSEC specific methylation blocks (n=89). (F) Fold change in LSEC cfDNA Geq at EOT and recovery relative to baseline levels. * Geq were calculated by multiplying the relative fraction of cell-type specific cfDNA x initial concentration cfDNA ng/mL x 3.3 x 10 -12 grams per haploid genome equivalent. Wilcoxon matched pairs signed rank test was performed between groups and results were considered significant when *P < 0.05; ns, P ≥ 0.05.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A, B) Hepatocyte cfDNA (in Geq/mL) in serum samples collected at different times. Fragment-level deconvolution used hepatocyte specific methylation blocks (top n=200). (C) Fold change in hepatocyte cfDNA after treatment (EOT) and at recovery relative to baseline. (D, E) Liver sinusoidal endothelial (LSEC) cfDNA (in Geq/mL) in the same serum samples. Fragment-level deconvolution used LSEC specific methylation blocks (n=89). (F) Fold change in LSEC cfDNA Geq at EOT and recovery relative to baseline levels. * Geq were calculated by multiplying the relative fraction of cell-type specific cfDNA x initial concentration cfDNA ng/mL x 3.3 x 10 -12 grams per haploid genome equivalent. Wilcoxon matched pairs signed rank test was performed between groups and results were considered significant when *P < 0.05; ns, P ≥ 0.05.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Methylation, Concentration Assay

(A) Lung epithelial cfDNA (in Geq/mL) in serum samples collected at different times. Fragment-level deconvolution used lung epithelial specific methylation blocks (n=69). (B) Correlation of lung epithelial cfDNA with dosimetry data. EOT/Baseline represents the fraction of lung epithelial cfDNA post-radiation at end-of-treatment (EOT) relative to baseline levels. The volume of the lung receiving 20 Gy dose is represented by Lung v20 (Gy) and the mean dose to the total body represented by total body mean (Gy). (C) Fold change in lung epithelial cfDNA at EOT and recovery relative to baseline. (D) Cardiopulmonary endothelial (CPEC) cfDNA (in Geq/mL). Fragment-level deconvolution used CPEC specific methylation blocks (n=132). (E) Correlation of CPEC cfDNA with dosimetry data. The volume of the lung receiving 5 Gy dose is represented by Lung v5 (Gy). (F) Fold change in CPEC cfDNA at EOT and recovery relative to baseline levels. (G) Cardiomyocyte cfDNA (in Geq/mL). Fragment-level deconvolution used cardiomyocyte specific methylation blocks (top n=375). (H) Correlation of cardiomyocyte cfDNA with the maximal heart dose (Gy). (I) Fold change in cardiomyocyte cfDNA at EOT and recovery relative to baseline. *(A, D, G) Friedman test was performed comparing paired results at baseline, EOT, and recovery timepoints. The results were considered significant when *P < 0.05. (B, E, H) Pearson correlation r was calculated, and linear correlation was considered significant when *P < 0.05. (C, F, I) Wilcoxon matched pairs signed rank test was performed between groups and results were considered significant when *P < 0.05; ns, P ≥ 0.05.

Journal: bioRxiv

Article Title: Cell-free, methylated DNA in blood samples reveals tissue-specific, cellular damage from radiation treatment

doi: 10.1101/2022.04.12.487966

Figure Lengend Snippet: (A) Lung epithelial cfDNA (in Geq/mL) in serum samples collected at different times. Fragment-level deconvolution used lung epithelial specific methylation blocks (n=69). (B) Correlation of lung epithelial cfDNA with dosimetry data. EOT/Baseline represents the fraction of lung epithelial cfDNA post-radiation at end-of-treatment (EOT) relative to baseline levels. The volume of the lung receiving 20 Gy dose is represented by Lung v20 (Gy) and the mean dose to the total body represented by total body mean (Gy). (C) Fold change in lung epithelial cfDNA at EOT and recovery relative to baseline. (D) Cardiopulmonary endothelial (CPEC) cfDNA (in Geq/mL). Fragment-level deconvolution used CPEC specific methylation blocks (n=132). (E) Correlation of CPEC cfDNA with dosimetry data. The volume of the lung receiving 5 Gy dose is represented by Lung v5 (Gy). (F) Fold change in CPEC cfDNA at EOT and recovery relative to baseline levels. (G) Cardiomyocyte cfDNA (in Geq/mL). Fragment-level deconvolution used cardiomyocyte specific methylation blocks (top n=375). (H) Correlation of cardiomyocyte cfDNA with the maximal heart dose (Gy). (I) Fold change in cardiomyocyte cfDNA at EOT and recovery relative to baseline. *(A, D, G) Friedman test was performed comparing paired results at baseline, EOT, and recovery timepoints. The results were considered significant when *P < 0.05. (B, E, H) Pearson correlation r was calculated, and linear correlation was considered significant when *P < 0.05. (C, F, I) Wilcoxon matched pairs signed rank test was performed between groups and results were considered significant when *P < 0.05; ns, P ≥ 0.05.

Article Snippet: Cryopreserved passage 2 human coronary artery (HCAEC SKU#C-14022), cardiac microvascular (HCMEC SKU#C-14029), and pulmonary artery endothelial cells (HPAEC SKU#C-14024) were isolated from single donor healthy human tissues purchased from PromoCell.

Techniques: Methylation

LPS induces GSK-3beta activation in dose- and time-dependent manners in HPMECs. Expression of P-GSK-3beta and GSK-3beta was detected after incubation with different concentrations of LPS for 1 h (A) . The expression of P-GSK-3beta was represented as a histogram according to band intensities (B) . Expression of P-GSK-3beta and GSK-3beta was examined at indicated time points after stimulation with LPS (0.1 μg/ml) in HPMECs (C) . The Western blotting results are presented as a histogram showing the band intensity values (D) . * P < 0.05 vs. LPS un-treatment group.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury

doi: 10.3389/fcimb.2017.00357

Figure Lengend Snippet: LPS induces GSK-3beta activation in dose- and time-dependent manners in HPMECs. Expression of P-GSK-3beta and GSK-3beta was detected after incubation with different concentrations of LPS for 1 h (A) . The expression of P-GSK-3beta was represented as a histogram according to band intensities (B) . Expression of P-GSK-3beta and GSK-3beta was examined at indicated time points after stimulation with LPS (0.1 μg/ml) in HPMECs (C) . The Western blotting results are presented as a histogram showing the band intensity values (D) . * P < 0.05 vs. LPS un-treatment group.

Article Snippet: Primary human pulmonary micro-vascular endothelial cells (HPMECs) were obtained ScienCell Research Laboratories and maintained in ScienCell Endothelial Cell Medium in a humidified 37°C, 5% CO 2 incubator.

Techniques: Activation Assay, Expressing, Incubation, Western Blot

Involvement of GSK-3beta in LPS-induced GEF-H1/ROCK signaling activation. HPMECs were incubated with LPS (0.1 μg/ml) at different indicated times, and the GEF-H1 and myosin-associated phosphatase type 1 (P-MYPT 1: the substrate of ROCK) were detected by Western blot assay (A) . The expression of GEF-H1 and P-MYPT 1 were represented as a histogram according to band intensities (B) . * < 0.05 vs. LPS un-treatment group. Inhibition effect of GSK-3beta activity in HPMECs was analyzed by Western blot (C,D) . * P < 0.05 vs. the negative control group, # P < 0.05 vs. the corresponding LPS treatment group. HPMECs were pretreated with SB-216763 (20 μM) for 1 h and then were exposed to LPS (0.1 μg/ml) for 1 h. The expression of GEF-H1 and P-MYPT 1 were determined by Western blot (E) . The Western blotting results are presented as a histogram showing the band intensity values (F) . * P < 0.05 vs. the negative control group, # P < 0.05 vs. the corresponding LPS treatment group.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury

doi: 10.3389/fcimb.2017.00357

Figure Lengend Snippet: Involvement of GSK-3beta in LPS-induced GEF-H1/ROCK signaling activation. HPMECs were incubated with LPS (0.1 μg/ml) at different indicated times, and the GEF-H1 and myosin-associated phosphatase type 1 (P-MYPT 1: the substrate of ROCK) were detected by Western blot assay (A) . The expression of GEF-H1 and P-MYPT 1 were represented as a histogram according to band intensities (B) . * < 0.05 vs. LPS un-treatment group. Inhibition effect of GSK-3beta activity in HPMECs was analyzed by Western blot (C,D) . * P < 0.05 vs. the negative control group, # P < 0.05 vs. the corresponding LPS treatment group. HPMECs were pretreated with SB-216763 (20 μM) for 1 h and then were exposed to LPS (0.1 μg/ml) for 1 h. The expression of GEF-H1 and P-MYPT 1 were determined by Western blot (E) . The Western blotting results are presented as a histogram showing the band intensity values (F) . * P < 0.05 vs. the negative control group, # P < 0.05 vs. the corresponding LPS treatment group.

Article Snippet: Primary human pulmonary micro-vascular endothelial cells (HPMECs) were obtained ScienCell Research Laboratories and maintained in ScienCell Endothelial Cell Medium in a humidified 37°C, 5% CO 2 incubator.

Techniques: Activation Assay, Incubation, Western Blot, Expressing, Inhibition, Activity Assay, Negative Control

GSK-3beta signaling is involved in LPS-induced HPMECs barrier disruption. The HPMECs were plated on the gold microelectrodes. When HPMECs formed monolayers and reached stable TER values, the SB-216763 (20 μM) was added. After 1 h, the medium or LPS (0.1 μg/ml) was added for another 6 h. The HPMEC monolayers permeability was determined by real-time TER measurement (A) . The results of the 3 h LPS stimulation were represented as a histogram in (B) according to the TER curves. * P < 0.05 vs. negative control. # P < 0.05 vs. corresponding LPS-stimulated group.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury

doi: 10.3389/fcimb.2017.00357

Figure Lengend Snippet: GSK-3beta signaling is involved in LPS-induced HPMECs barrier disruption. The HPMECs were plated on the gold microelectrodes. When HPMECs formed monolayers and reached stable TER values, the SB-216763 (20 μM) was added. After 1 h, the medium or LPS (0.1 μg/ml) was added for another 6 h. The HPMEC monolayers permeability was determined by real-time TER measurement (A) . The results of the 3 h LPS stimulation were represented as a histogram in (B) according to the TER curves. * P < 0.05 vs. negative control. # P < 0.05 vs. corresponding LPS-stimulated group.

Article Snippet: Primary human pulmonary micro-vascular endothelial cells (HPMECs) were obtained ScienCell Research Laboratories and maintained in ScienCell Endothelial Cell Medium in a humidified 37°C, 5% CO 2 incubator.

Techniques: Disruption, Permeability, Negative Control

LPS induces degradation of beta-catenin and ZO-1 in HPMECs monolayer. LPS (0.1 μg/ml) induced down-regulation of ZO-1 expression and increase of phosphorylated degradation of beta-catenin in a time-dependent manner (A) . The Western blotting results are presented as a histogram showing the band intensity values (B) . * P < 0.05 vs. LPS un-treatment group.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury

doi: 10.3389/fcimb.2017.00357

Figure Lengend Snippet: LPS induces degradation of beta-catenin and ZO-1 in HPMECs monolayer. LPS (0.1 μg/ml) induced down-regulation of ZO-1 expression and increase of phosphorylated degradation of beta-catenin in a time-dependent manner (A) . The Western blotting results are presented as a histogram showing the band intensity values (B) . * P < 0.05 vs. LPS un-treatment group.

Article Snippet: Primary human pulmonary micro-vascular endothelial cells (HPMECs) were obtained ScienCell Research Laboratories and maintained in ScienCell Endothelial Cell Medium in a humidified 37°C, 5% CO 2 incubator.

Techniques: Expressing, Western Blot

GSK-3beta/GEF-H1/ROCK signaling is required for LPS-induced degradation of beta-catenin and ZO-1. After transfection with GEF-H1 siRNA and Control siRNA for 48 h, HPMECs were treated with SB-216763 (20 μM) and/or Y-27632 (10 μM) for another 1 h prior to LPS stimulation (0.1 μg/ml) for 3 h. The expression of ZO-1 was determined by immunoblotting, and GAPDH protein was used as loading control (A) . The Western blotting results are presented as a histogram showing the band intensity values (B) . The expression of P-beta-catenin was determined by immunoblotting, and GSK-3beta and GAPDH proteins were used as control (C) . The Western blotting results are presented as a histogram showing the band intensity values (D) . * P < 0.05 vs. negative control. # P < 0.05 vs. corresponding LPS-stimulated group. NS, no significance.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury

doi: 10.3389/fcimb.2017.00357

Figure Lengend Snippet: GSK-3beta/GEF-H1/ROCK signaling is required for LPS-induced degradation of beta-catenin and ZO-1. After transfection with GEF-H1 siRNA and Control siRNA for 48 h, HPMECs were treated with SB-216763 (20 μM) and/or Y-27632 (10 μM) for another 1 h prior to LPS stimulation (0.1 μg/ml) for 3 h. The expression of ZO-1 was determined by immunoblotting, and GAPDH protein was used as loading control (A) . The Western blotting results are presented as a histogram showing the band intensity values (B) . The expression of P-beta-catenin was determined by immunoblotting, and GSK-3beta and GAPDH proteins were used as control (C) . The Western blotting results are presented as a histogram showing the band intensity values (D) . * P < 0.05 vs. negative control. # P < 0.05 vs. corresponding LPS-stimulated group. NS, no significance.

Article Snippet: Primary human pulmonary micro-vascular endothelial cells (HPMECs) were obtained ScienCell Research Laboratories and maintained in ScienCell Endothelial Cell Medium in a humidified 37°C, 5% CO 2 incubator.

Techniques: Transfection, Control, Expressing, Western Blot, Negative Control

GSK-3beta/GEF-H1/ROCK pathway is involved in LPS-induced HPMECs barrier disruption by beta-catenin and ZO-1. HPMECs monolayer was pretreated with SB-216763 (20 μM) (A) , GEF-H1 siRNA (B) , or Y-27632 (10 μM) (C) , for indicated times and then was exposed to LPS (0.1 μg/ml) for 3 h before fixation and staining with anti-beta-catenin and anti-ZO-1 antibody as described in Materials and Methods. Beta-catenin (green) and ZO-1 (green) were visualized by immunofluorescence microscopy. Red arrows not only represent the expression of beta-catenin and ZO-1 in the membrane of HPMECs but also represent the cell-cell gaps formation in the ECs monolayer.

Journal: Frontiers in Cellular and Infection Microbiology

Article Title: GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury

doi: 10.3389/fcimb.2017.00357

Figure Lengend Snippet: GSK-3beta/GEF-H1/ROCK pathway is involved in LPS-induced HPMECs barrier disruption by beta-catenin and ZO-1. HPMECs monolayer was pretreated with SB-216763 (20 μM) (A) , GEF-H1 siRNA (B) , or Y-27632 (10 μM) (C) , for indicated times and then was exposed to LPS (0.1 μg/ml) for 3 h before fixation and staining with anti-beta-catenin and anti-ZO-1 antibody as described in Materials and Methods. Beta-catenin (green) and ZO-1 (green) were visualized by immunofluorescence microscopy. Red arrows not only represent the expression of beta-catenin and ZO-1 in the membrane of HPMECs but also represent the cell-cell gaps formation in the ECs monolayer.

Article Snippet: Primary human pulmonary micro-vascular endothelial cells (HPMECs) were obtained ScienCell Research Laboratories and maintained in ScienCell Endothelial Cell Medium in a humidified 37°C, 5% CO 2 incubator.

Techniques: Disruption, Staining, Immunofluorescence, Microscopy, Expressing, Membrane